EGAGenomicsIllumina HiSeq 2000Cancer Genomicshttps://ega-archive.org/studies/EGAS00001000278EGAEGA study EGAS00001000278Osteosarcoma Targeted Sequencing StudyEGArestrictedOsteosarcoma of bone (disorder), Skeletal sarcoma, Bone Sarcoma, Osteochondrosarcoma, Sarcomas, Osteosarcoma of bone, Sarcoma of the Bone, Osteogenic Sarcomas, Osteogenic sarcoma, Osteosarcoma - disorder, Sarcoma of Bone, osteoid sarcoma, study., Osteosarcoma, Tumor, Osteogenic, Osteoblastic sarcoma, Osseous Sarcoma, bone tissue neoplasm, Osteogenic Sarcoma, Sarcoma, no ICD-O subtype, no ICD-O subtype (morphologic abnormality), [M]Osteosarcoma NOS, Osteosarcoma Tumors, Osteosarcoma Tumor, NOS, Osteoblastic osteosarcoma, osteosarcoma, Tumors, OsteosarcomasOsteosarcoma of bone (disorder), Osteochondrosarcoma, IPP2A2, Osteogenic Sarcomas, Procedures, Complete Exome, Tumor, PHAPII, 5730420M11Rik, Osteogenic Sarcoma, method, Techniques, Client., Method, method used in an experiment, Studies, symptoms, Whole Transcriptome, Transcriptome Sequencing, Osteoblastic osteosarcoma, Technique, study, Sarcomas, SET, WES, Complete, Exome Sequencings, TAF-I, Sarcoma of Bone, Complete Exome Sequencing, Whole Transcriptome Sequencing, ipp2a2, 2pp2a, Osteoblastic sarcoma, Osseous Sarcoma, Sequencing, CG10574, DmelCG4299, Study, IGAAD, set, Sarcoma, Whole Exome, 2PP2A, Methodological Studies, DmelCG10574, no ICD-O subtype (morphologic abnormality), taf-ibeta, Clients, Whole, dSET, dSet, Tumors, phapii, screening, Osteosarcoma of bone, findings, Complete Exome Sequencings, Osteogenic sarcoma, Osteosarcoma - disorder, Exome, igaad, StF-IT-1, Procedure, Osteogenic, group, Exome Sequencing, I-2PP2A, [M]Osteosarcoma NOS, Dm I-2, I2PP2A, NOS, Library, Osteosarcomas, Skeletal sarcoma, Bone Sarcoma, Complete Transcriptome, Sarcoma of the Bone, Complete Transcriptome Sequencing, HLA-DR-associated protein II, ensemble, DI-2, I-2Dm, osteoid sarcoma, signs, Osteosarcoma, patient, Methodological, whole genome, CG4299, Methodological Study, bone tissue neoplasm, plan specification, I-2PP1, dSET/TAF-Ibeta, 2610030F17Rik, no ICD-O subtype, TAF-IBETA, Patient, Whole Exome Sequencing, Osteosarcoma Tumors, Osteosarcoma Tumor, TAF-Ibeta, AA407739, other neoplasm, Transcriptome Sequencings, i2pp2a, osteosarcomafalseOsteosarcoma Targeted Sequencing StudyThis Study uses a focused bespoke bait pull down library method to target findings of Osteosarcoma whole genome and whole exome sequencing studies in order to validate findings. This method will also be used on a larger set of tumour only samples in order to find precedence of these findings in a larger set of patient samples.2017-07-26 15:39:24EGAS000010002789606EGAD00001000266EGAC00001000000